杨梅素的药理活性及其作用机制研究进展  

Advances in Pharmacological Activity and Action Mechanism of Myricetin

作　　者：张杨 张浩超 郝宝燕[3] 孙敬勇[1,2] ZHANG Yang;ZHANG Hao-chao;HAO Bao-yan;SUN Jing-yong(School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences, Jinan 250022, China;Key Laboratory of Rare and Uncommon Diseases, Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, China;Jinan Tianqiao Hospital, Jinan 250031, China)

机构地区：[1]济南大学山东省医学科学院医学与生命科学学院,山东济南250200 [2]山东省医学科学院药物研究所山东省罕少见病重点实验室,山东济南250062 [3]山东省济南市天桥人民医院,山东济南250031

出　　处：《食品与药品》2019年第1期75-80,共6页Food and Drug

基　　金：山东省教育厅山东省高校科技发展计划项目(编号J15LM07);山东省医学科学院医药卫生科技创新工程

摘　　要：杨梅素是自然界广泛分布的一种黄酮类化合物,多项研究表明杨梅素具有抗癌、抗氧化、抗炎、抗菌和镇痛等药理活性。本文对近年有关杨梅素的药理活性和作用机制进行综述,以期为杨梅素的进一步研究提供参考。Myricetin is flavonoid compound widely distributed in natural plants. Recently, several studies have shown that myricetin has anti-cancer, antioxidant, antibacterial, anti-inflammatory, analgesic and many other pharmacological activities. Through literature retrieval, the pharmacological effects and action mechanism of myricetin are reviewed in this article, thus to provide reference for the further study on myricetin.

关 键 词：杨梅素 细胞周期调节 抗癌活性 抗氧化活性 细胞凋亡 

分 类 号：R285[医药卫生—中药学]